AR033260A1 - Nueva composicion hormonal y su utilizacion - Google Patents
Nueva composicion hormonal y su utilizacionInfo
- Publication number
- AR033260A1 AR033260A1 ARP020101475A ARP020101475A AR033260A1 AR 033260 A1 AR033260 A1 AR 033260A1 AR P020101475 A ARP020101475 A AR P020101475A AR P020101475 A ARP020101475 A AR P020101475A AR 033260 A1 AR033260 A1 AR 033260A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- estrogenic
- association
- new
- stroprogestative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Dominio de la química terapéutica, y más particularmente dominio de la técnica farmacéutica hormonal. Nuevas composiciones farmacéuticas hormonales formadas por una asociacion estroprogestativa constituida por un compuesto estrogeno y un compuesto progestativo, en asociacion o mezclado con varios excipientes no toxicos, inertes, farmacéuticamente aceptables, destinadas a la administracion por vía bucal.Uso de una mezcla estroprogestativa en que el compuesto estrogénico y el compuesto progestativo se administran de una manera combinada la asociacion combinada puede ser prescripta de una manera continua o intermitente mediante la preparacion de un compuesto destinado al tratamiento de carencias estrogénicas, evitar la osteoporosis y las enfermedades, en la mujer menopáusica. Un procedimiento para la preparacion de estas nuevas composiciones farmacéuticas estroprogestativas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0105557A FR2823976A1 (fr) | 2001-04-25 | 2001-04-25 | Nouvelle composition hormonale et son utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
AR033260A1 true AR033260A1 (es) | 2003-12-10 |
Family
ID=8862668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020101475A AR033260A1 (es) | 2001-04-25 | 2002-04-24 | Nueva composicion hormonal y su utilizacion |
Country Status (9)
Country | Link |
---|---|
KR (1) | KR20030043797A (es) |
CN (1) | CN1464787A (es) |
AR (1) | AR033260A1 (es) |
AU (1) | AU2002310721A1 (es) |
BR (1) | BR0205104A (es) |
FR (1) | FR2823976A1 (es) |
MA (1) | MA26833A1 (es) |
NO (1) | NO20026215L (es) |
WO (1) | WO2002085375A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8022053B2 (en) | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
UY29185A1 (es) * | 2004-11-02 | 2006-05-31 | Schering Ag | Formas de dosificación oral sólidas que contienen una dosis baja de estradiol |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
US5208225A (en) * | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
FR2754179B1 (fr) * | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
-
2001
- 2001-04-25 FR FR0105557A patent/FR2823976A1/fr not_active Withdrawn
-
2002
- 2002-04-15 MA MA26603A patent/MA26833A1/fr unknown
- 2002-04-23 WO PCT/FR2002/001384 patent/WO2002085375A1/fr not_active Application Discontinuation
- 2002-04-23 CN CN02802212A patent/CN1464787A/zh active Pending
- 2002-04-23 BR BR0205104-4A patent/BR0205104A/pt not_active Application Discontinuation
- 2002-04-23 AU AU2002310721A patent/AU2002310721A1/en not_active Abandoned
- 2002-04-23 KR KR1020027017624A patent/KR20030043797A/ko not_active Application Discontinuation
- 2002-04-24 AR ARP020101475A patent/AR033260A1/es not_active Application Discontinuation
- 2002-12-23 NO NO20026215A patent/NO20026215L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2002310721A1 (en) | 2002-11-05 |
BR0205104A (pt) | 2003-05-20 |
MA26833A1 (fr) | 2004-12-20 |
NO20026215D0 (no) | 2002-12-23 |
CN1464787A (zh) | 2003-12-31 |
NO20026215L (no) | 2003-02-21 |
FR2823976A1 (fr) | 2002-10-31 |
WO2002085375A1 (fr) | 2002-10-31 |
KR20030043797A (ko) | 2003-06-02 |
WO2002085375A8 (fr) | 2003-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200201000A1 (ru) | Гормон-заместительная терапия | |
EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
EA200301022A1 (ru) | Гормональная заместительная терапия | |
EA200600964A1 (ru) | Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина | |
EA201201221A1 (ru) | Фармацевтическая композиция для контрацепции и заместительной гормональной терапии | |
HUP0102913A2 (hu) | Biogén ösztrogén-szulfamátok alkalmazása hormonhelyettesítő terápiánál használható gyógyszerkészítmények előállítására | |
TNSN04048A1 (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
AP1625A (en) | Hormonal composition based on a progesterone and an oestrogen and use thereof. | |
HUP0301460A2 (hu) | Antiprogresztinek használata hormonfüggő betegségek megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállításához | |
AR046036A1 (es) | Composiciones de risedronato y metodos para su uso | |
MY128482A (en) | New hormonal composition and its use | |
AR065816A1 (es) | Regimen anticonceptivo oral | |
HUP0500346A2 (hu) | Konjugált ösztrogének alkalmazása ösztrogénpótó terápiában hatásos gyógyszerkészítmények előállítására | |
ES2303811T1 (es) | Uso de anastrozol para el tratamiento post-menopausico de una mujer que tiene cancer de mama temprano. | |
AR033260A1 (es) | Nueva composicion hormonal y su utilizacion | |
CR6627A (es) | Nuevo medicamento contraceptivo y su modo de preparacion | |
HUP0004461A2 (hu) | Apoliprotein B kiválasztást/mikroszomális trigliceridtranszfer-proteint gátló anyag alkalmazása gyógyászati készítmények előállítására és a fenti gyógyászati készítmények | |
EA201000097A1 (ru) | 8-бета-замещенные эстратриены в качестве селективно активных эстрогенов | |
AR039227A1 (es) | Terapia de reemplazo hormonal | |
AR039228A1 (es) | Terapia de reemplazo hormonal | |
AR039477A1 (es) | Terapia de reemplazo hormonal | |
DK1462107T3 (da) | Fremgangsmåde til kvindelig kontraception og kit til anvendelse i en sådan fremgangsmåde | |
CR6628A (es) | Nueva composicion hormonal y su utilizacion | |
EP1857110A3 (en) | Hormone replacement therapy | |
HRP20020666B1 (en) | Drospirenone for hormone replacement therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |